{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:36:11Z","timestamp":1790678171579,"version":"4.1.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Apoptosis"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10495-019-01586-0","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T13:03:01Z","timestamp":1581598981000},"page":"179-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["BRAFi induced demethylation of miR-152-5p regulates phenotype switching by targeting TXNIP in cutaneous melanoma"],"prefix":"10.1007","volume":"25","author":[{"given":"Kezhu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3859-505X","authenticated-orcid":false,"given":"Shifeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"1586_CR1","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1038\/ncomms7683","volume":"6","author":"A Verfaillie","year":"2015","unstructured":"Verfaillie A, Imrichova H, Atak ZK, Dewaele M, Rambow F, Hulselmans G et al (2015) Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. Nat Commun 6:6683","journal-title":"Nat Commun"},{"issue":"7653","key":"1586_CR2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward NK, Wilmott JS, Waddell N, Johansson PA, Field MA, Nones K et al (2017) Whole-genome landscapes of major melanoma subtypes. Nature 545(7653):175\u2013180","journal-title":"Nature"},{"issue":"7","key":"1586_CR3","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Cancer Genome Atlas N","year":"2015","unstructured":"Cancer Genome Atlas N (2015) Genomic classification of cutaneous melanoma. Cell 161(7):1681\u20131696","journal-title":"Cell"},{"issue":"3","key":"1586_CR4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1755-148X.2012.00986.x","volume":"25","author":"DS Widmer","year":"2012","unstructured":"Widmer DS, Cheng PF, Eichhoff OM, Belloni BC, Zipser MC, Schlegel NC et al (2012) Systematic classification of melanoma cells by phenotype-specific gene expression mapping. Pigment Cell Melanoma Res 25(3):343\u2013353","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"1586_CR5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1755-148X.2008.00534.x","volume":"22","author":"HW Richards","year":"2009","unstructured":"Richards HW, Medrano EE (2009) Epigenetic marks in melanoma. Pigment Cell Melanoma Res 22(1):14\u201329","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"1586_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12916-017-0851-3","volume":"15","author":"J Wouters","year":"2017","unstructured":"Wouters J, Vizoso M, Martinez-Cardus A, Carmona FJ, Govaere O, Laguna T et al (2017) Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma. BMC Med 15(1):101","journal-title":"BMC Med"},{"issue":"1","key":"1586_CR7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/2159-8290.CD-13-0642","volume":"4","author":"H Shi","year":"2013","unstructured":"Shi H, Hugo W, Kong X, Hong A, Koya RC, Moriceau G et al (2013) Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer Discov 4(1):80\u201393","journal-title":"Cancer Discov"},{"issue":"12","key":"1586_CR8","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1002\/ijc.30241","volume":"140","author":"R Maxwell","year":"2017","unstructured":"Maxwell R, Garzon-Muvdi T, Lipson EJ, Sharfman WH, Bettegowda C, Redmond KJ et al (2017) BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis. Int J Cancer 140(12):2716\u20132727","journal-title":"Int J Cancer"},{"issue":"3","key":"1586_CR9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1158\/1535-7163.MCT-14-0701","volume":"14","author":"V Paulitschke","year":"2015","unstructured":"Paulitschke V, Berger W, Paulitschke P, Hofstatter E, Knapp B, Dingelmaier-Hovorka R et al (2015) Vemurafenib resistance signature by proteome analysis offers new strategies and rational therapeutic concepts. Mol Cancer Ther 14(3):757\u2013768","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1586_CR10","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2015.02.041","volume":"361","author":"I Zubrilov","year":"2015","unstructured":"Zubrilov I, Sagi-Assif O, Izraely S, Meshel T, Ben-Menahem S, Ginat R et al (2015) Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells. Cancer Lett 361(1):86\u201396","journal-title":"Cancer Lett"},{"issue":"12","key":"1586_CR11","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/2159-8290.CD-13-0005","volume":"3","author":"MP O'Connell","year":"2013","unstructured":"O'Connell MP, Marchbank K, Webster MR, Valiga AA, Kaur A, Vultur A et al (2013) Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2. Cancer Discov 3(12):1378\u20131393","journal-title":"Cancer Discov"},{"issue":"2","key":"1586_CR12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/jid.2014.418","volume":"135","author":"J Wang","year":"2015","unstructured":"Wang J, Huang SK, Marzese DM, Hsu SC, Kawas NP, Chong KK et al (2015) Epigenetic changes of EGFR have an important role in BRAF inhibitor-resistant cutaneous melanomas. J Investig Dermatol 135(2):532\u2013541","journal-title":"J Investig Dermatol"},{"issue":"6","key":"1586_CR13","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.molonc.2012.09.006","volume":"6","author":"MD Jansson","year":"2012","unstructured":"Jansson MD, Lund AH (2012) MicroRNA and cancer. Mol Oncol 6(6):590\u2013610","journal-title":"Mol Oncol"},{"issue":"4","key":"1586_CR14","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1158\/0008-5472.CAN-17-1318","volume":"78","author":"M Diaz-Martinez","year":"2018","unstructured":"Diaz-Martinez M, Benito-Jardon L, Alonso L, Koetz-Ploch L, Hernando E, Teixido J (2018) miR-204-5p and miR-211-5p contribute to BRAF inhibitor resistance in melanoma. Cancer Res 78(4):1017\u20131030","journal-title":"Cancer Res"},{"issue":"1","key":"1586_CR15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jid.2018.06.189","volume":"139","author":"A Sahoo","year":"2019","unstructured":"Sahoo A, Sahoo SK, Joshi P, Lee B, Perera RJ (2019) MicroRNA-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma. J Investig Dermatol 139(1):167\u2013176","journal-title":"J Investig Dermatol"},{"issue":"7","key":"1586_CR16","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41418-018-0205-5","volume":"26","author":"L Fattore","year":"2019","unstructured":"Fattore L, Ruggiero CF, Pisanu ME, Liguoro D, Cerri A, Costantini S et al (2019) Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma. Cell Death Differ 26(7):1267\u20131282","journal-title":"Cell Death Differ"},{"issue":"6","key":"1586_CR17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ncb2769","volume":"15","author":"N Pencheva","year":"2013","unstructured":"Pencheva N, Tavazoie SF (2013) Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol 15(6):546\u2013554","journal-title":"Nat Cell Biol"},{"issue":"6","key":"1586_CR18","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jid.2016.02.803","volume":"136","author":"F Rambow","year":"2016","unstructured":"Rambow F, Bechadergue A, Luciani F, Gros G, Domingues M, Bonaventure J et al (2016) Regulation of melanoma progression through the TCF4\/miR-125b\/NEDD9 cascade. J Investig Dermatol 136(6):1229\u20131237","journal-title":"J Investig Dermatol"},{"issue":"3","key":"1586_CR19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1755-148X.2011.00849.x","volume":"24","author":"GM Boyle","year":"2011","unstructured":"Boyle GM, Woods SL, Bonazzi VF, Stark MS, Hacker E, Aoude LG et al (2011) Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell Melanoma Res 24(3):525\u2013537","journal-title":"Pigment Cell Melanoma Res"},{"issue":"24","key":"1586_CR20","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1038\/onc.2012.307","volume":"32","author":"M Kappelmann","year":"2013","unstructured":"Kappelmann M, Kuphal S, Meister G, Vardimon L, Bosserhoff AK (2013) MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. Oncogene 32(24):2984\u20132991","journal-title":"Oncogene"},{"issue":"2","key":"1586_CR21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/jid.2013.340","volume":"134","author":"RE Bell","year":"2014","unstructured":"Bell RE, Khaled M, Netanely D, Schubert S, Golan T, Buxbaum A et al (2014) Transcription factor\/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1. J Invest Dermatol 134(2):441\u2013451","journal-title":"J Invest Dermatol"},{"issue":"8","key":"1586_CR22","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.7150\/thno.18835","volume":"7","author":"W Guo","year":"2017","unstructured":"Guo W, Wang H, Yang Y, Guo S, Zhang W, Liu Y et al (2017) Down-regulated miR-23a contributes to the metastasis of cutaneous melanoma by promoting autophagy. Theranostics 7(8):2231\u20132249","journal-title":"Theranostics"},{"key":"1586_CR23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2147\/OTT.S128819","volume":"10","author":"W Luan","year":"2017","unstructured":"Luan W, Qian Y, Ni X, Bu X, Xia Y, Wang J et al (2017) miR-204-5p acts as a tumor suppressor by targeting matrix metalloproteinases-9 and B-cell lymphoma-2 in malignant melanoma. OncoTargets Ther 10:1237\u20131246","journal-title":"OncoTargets Ther"},{"issue":"3","key":"1586_CR24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ncb3110","volume":"17","author":"E Shoshan","year":"2015","unstructured":"Shoshan E, Mobley AK, Braeuer RR, Kamiya T, Huang L, Vasquez ME et al (2015) Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis. Nat Cell Biol 17(3):311\u2013321","journal-title":"Nat Cell Biol"},{"issue":"6","key":"1586_CR25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/labinvest.2017.5","volume":"97","author":"S Babapoor","year":"2017","unstructured":"Babapoor S, Wu R, Kozubek J, Auidi D, Grant-Kels JM, Dadras SS (2017) Identification of microRNAs associated with invasive and aggressive phenotype in cutaneous melanoma by next-generation sequencing. Lab Investig 97(6):636\u2013648","journal-title":"Lab Investig"},{"issue":"1","key":"1586_CR26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-4598-12-43","volume":"12","author":"Y Chen","year":"2013","unstructured":"Chen Y, Song YX, Wang ZN (2013) The microRNA-148\/152 family: multi-faceted players. Mol Cancer 12(1):43","journal-title":"Mol Cancer"},{"issue":"1","key":"1586_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2014.09.012","volume":"355","author":"J Ma","year":"2014","unstructured":"Ma J, Yao YL, Wang P, Liu YH, Zhao LN, Li ZQ et al (2014) MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Kruppel-like factor 4. Cancer Lett 355(1):85\u201395","journal-title":"Cancer Lett"},{"issue":"2","key":"1586_CR28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.canlet.2012.10.026","volume":"329","author":"X Zheng","year":"2013","unstructured":"Zheng X, Chopp M, Lu Y, Buller B, Jiang F (2013) MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3. Cancer Lett 329(2):146\u2013154","journal-title":"Cancer Lett"},{"issue":"13","key":"1586_CR29","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/hmg\/ddx138","volume":"26","author":"K Daniunaite","year":"2017","unstructured":"Daniunaite K, Dubikaityte M, Gibas P, Bakavicius A, Rimantas Lazutka J, Ulys A et al (2017) Clinical significance of miRNA host gene promoter methylation in prostate cancer. Hum Mol Genet 26(13):2451\u20132461","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1586_CR30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/leu.2010.282","volume":"25","author":"DJ Stumpel","year":"2011","unstructured":"Stumpel DJ, Schotte D, Lange-Turenhout EA, Schneider P, Seslija L, de Menezes RX et al (2011) Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale. Leukemia 25(3):429\u2013439","journal-title":"Leukemia"},{"issue":"20","key":"1586_CR31","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1158\/0008-5472.CAN-11-0364","volume":"71","author":"T Tsuruta","year":"2011","unstructured":"Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, Imoto I et al (2011) miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res 71(20):6450\u20136462","journal-title":"Cancer Res"},{"issue":"3","key":"1586_CR32","first-page":"881","volume":"51","author":"C Braconi","year":"2010","unstructured":"Braconi C, Huang N, Patel T (2010) MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 51(3):881\u2013890","journal-title":"Hepatology"},{"issue":"1","key":"1586_CR33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.23660","volume":"52","author":"J Huang","year":"2010","unstructured":"Huang J, Wang Y, Guo Y, Sun S (2010) Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 52(1):60\u201370","journal-title":"Hepatology"},{"issue":"4","key":"1586_CR34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/2159-8290.CD-13-0440","volume":"4","author":"TJ Parmenter","year":"2014","unstructured":"Parmenter TJ, Kleinschmidt M, Kinross KM, Bond ST, Li J, Kaadige MR et al (2014) Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. Cancer Discov 4(4):423\u2013433","journal-title":"Cancer Discov"},{"issue":"7680","key":"1586_CR35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature24294","volume":"551","author":"S Raffel","year":"2017","unstructured":"Raffel S, Falcone M, Kneisel N, Hansson J, Wang W, Lutz C et al (2017) BCAT1 restricts alphaKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation. Nature 551(7680):384\u2013388","journal-title":"Nature"},{"issue":"6","key":"1586_CR36","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1755-148X.2010.00757.x","volume":"23","author":"KS Hoek","year":"2010","unstructured":"Hoek KS, Goding CR (2010) Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res 23(6):746\u2013759","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"1586_CR37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrc3265","volume":"12","author":"T Brabletz","year":"2012","unstructured":"Brabletz T (2012) To differentiate or not \u2014 routes towards metastasis. Nat Rev Cancer 12(6):425\u2013436","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1586_CR38","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","volume":"68","author":"KS Hoek","year":"2008","unstructured":"Hoek KS, Eichhoff OM, Schlegel NC, Dobbeling U, Kobert N, Schaerer L et al (2008) In vivo switching of human melanoma cells between proliferative and invasive states. Can Res 68(3):650\u2013656","journal-title":"Can Res"},{"issue":"4","key":"1586_CR39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","volume":"24","author":"J Caramel","year":"2013","unstructured":"Caramel J, Papadogeorgakis E, Hill L, Browne GJ, Richard G, Wierinckx A et al (2013) A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma. Cancer Cell 24(4):466\u2013480","journal-title":"Cancer Cell"},{"issue":"8","key":"1586_CR40","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ncb2535","volume":"14","author":"O Shakhova","year":"2012","unstructured":"Shakhova O, Zingg D, Schaefer SM, Hari L, Civenni G, Blunschi J et al (2012) Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma. Nat Cell Biol 14(8):882\u2013890","journal-title":"Nat Cell Biol"},{"issue":"8","key":"1586_CR41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/cr.2014.67","volume":"24","author":"G Zhang","year":"2014","unstructured":"Zhang G, Herlyn M (2014) Linking SOX10 to a slow-growth resistance phenotype. Cell Res 24(8):906\u2013907","journal-title":"Cell Res"},{"issue":"1","key":"1586_CR42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41467-017-02354-x","volume":"9","author":"S Han","year":"2018","unstructured":"Han S, Ren Y, He W, Liu H, Zhi Z, Zhu X et al (2018) ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma. Nat Commun 9(1):28","journal-title":"Nat Commun"},{"issue":"6","key":"1586_CR43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ccr.2013.05.003","volume":"23","author":"A Roesch","year":"2013","unstructured":"Roesch A, Vultur A, Bogeski I, Wang H, Zimmermann KM, Speicher D et al (2013) Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B high cells. Cancer Cell 23(6):811\u2013825","journal-title":"Cancer Cell"},{"issue":"4","key":"1586_CR44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1755-148X.2010.00726.x","volume":"23","author":"M Held","year":"2010","unstructured":"Held M, Bosenberg M (2010) A role for the JARID1B stem cell marker for continuous melanoma growth. Pigment Cell Melanoma Res 23(4):481\u2013483","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"1586_CR45","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1158\/1535-7163.MCT-16-0535","volume":"16","author":"A Ahn","year":"2017","unstructured":"Ahn A, Chatterjee A, Eccles MR (2017) The slow cycling phenotype: a growing problem for treatment resistance in melanoma. Mol Cancer Ther 16(6):1002\u20131009","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"1586_CR46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/onc.2017.341","volume":"37","author":"M Perego","year":"2017","unstructured":"Perego M, Maurer M, Wang JX, Shaffer S, M\u00fcller AC, Parapatics K et al (2017) A slow-cycling subpopulation of melanoma cells with highly invasive properties. Oncogene 37(3):302\u2013312","journal-title":"Oncogene"},{"issue":"6","key":"1586_CR47","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/jid.2013.6","volume":"133","author":"S Haferkamp","year":"2013","unstructured":"Haferkamp S, Borst A, Adam C, Becker TM, Motschenbacher S, Windhovel S et al (2013) Vemurafenib induces senescence features in melanoma cells. J Investig Dermatol 133(6):1601\u20131609","journal-title":"J Investig Dermatol"},{"issue":"7686","key":"1586_CR48","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature25167","volume":"553","author":"M Milanovic","year":"2018","unstructured":"Milanovic M, Fan DNY, Belenki D, Dabritz JHM, Zhao Z, Yu Y et al (2018) Senescence-associated reprogramming promotes cancer stemness. Nature 553(7686):96\u2013100","journal-title":"Nature"},{"issue":"4","key":"1586_CR49","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cmet.2018.03.009","volume":"27","author":"Z Dou","year":"2018","unstructured":"Dou Z, Berger SL (2018) Senescence elicits stemness: a surprising mechanism for cancer relapse. Cell Metab 27(4):710\u2013711","journal-title":"Cell Metab"},{"key":"1586_CR50","doi-asserted-by":"crossref","first-page":"e1711","DOI":"10.1038\/cddis.2015.71","volume":"6","author":"C Leikam","year":"2015","unstructured":"Leikam C, Hufnagel AL, Otto C, Murphy DJ, Muhling B, Kneitz S et al (2015) In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells. Cell Death Dis 6:e1711","journal-title":"Cell Death Dis"},{"issue":"6","key":"1586_CR51","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cmet.2007.05.011","volume":"5","author":"DM Muoio","year":"2007","unstructured":"Muoio DM (2007) TXNIP links redox circuitry to glucose control. Cell Metab 5(6):412\u2013414","journal-title":"Cell Metab"},{"issue":"12","key":"1586_CR52","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.15252\/embr.201439392","volume":"15","author":"S Knoll","year":"2014","unstructured":"Knoll S, Furst K, Kowtharapu B, Schmitz U, Marquardt S, Wolkenhauer O et al (2014) E2F1 induces miR-224\/452 expression to drive EMT through TXNIP downregulation. EMBO Rep 15(12):1315\u20131329","journal-title":"EMBO Rep"},{"issue":"2","key":"1586_CR53","first-page":"432","volume":"63","author":"SF Goldberg","year":"2003","unstructured":"Goldberg SF, Miele ME, Hatta N, Takata M, Paquette-Straub C, Freedman LP et al (2003) Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res 63(2):432\u2013440","journal-title":"Cancer Res"},{"issue":"2","key":"1586_CR54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yexcr.2004.07.014","volume":"300","author":"GC Cheng","year":"2004","unstructured":"Cheng GC, Schulze PC, Lee RT, Sylvan J, Zetter BR, Huang H (2004) Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cells. Exp Cell Res 300(2):297\u2013307","journal-title":"Exp Cell Res"},{"issue":"1","key":"1586_CR55","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cell.2018.08.017","volume":"175","author":"WJ Sullivan","year":"2018","unstructured":"Sullivan WJ, Mullen PJ, Schmid EW, Flores A, Momcilovic M, Sharpley MS et al (2018) Extracellular matrix remodeling regulates glucose metabolism through TXNIP destabilization. Cell 175(1):117","journal-title":"Cell"},{"issue":"11","key":"1586_CR56","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/bjc.2015.360","volume":"113","author":"BR Wilde","year":"2015","unstructured":"Wilde BR, Ayer DE (2015) Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis. Br J Cancer 113(11):1529\u20131533","journal-title":"Br J Cancer"}],"container-title":["Apoptosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-019-01586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10495-019-01586-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10495-019-01586-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T00:23:26Z","timestamp":1613089406000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10495-019-01586-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":56,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1586"],"URL":"https:\/\/doi.org\/10.1007\/s10495-019-01586-0","relation":{},"ISSN":["1360-8185","1573-675X"],"issn-type":[{"value":"1360-8185","type":"print"},{"value":"1573-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]},"assertion":[{"value":"13 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors confirm that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}